Table 2. The medical profile of the study subjects .
| Anti-TNF Therapy | ||
| Single therapy, n (%) | Switched therapy, n (%) | |
| CD, n (%) | 121 (75.6) | 39 (24.4) |
| UC, n (%) | 120 (77.4) | 35 (22.6) |
| CD &UC, n (%) | 241 (76.5) | 75 (23.5) |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.